Table of Contents
<< Previous Issue | Mar 2020 (Vol: 2020, Issue: 3) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Gilead Acquires CD47 Focused Forty Seven for US$4.9 B
-
Takeda Exercises Option to Acquire PvP Biologics
-
Thermo Fisher Acquires Molecular Diagnostics Specialist Qiagen for US$11.5 B
- Section: Opinion & Analysis
-
IQVIA Pharma Deals Review of 2019
- Section: Research & Development
-
Biogen Signs Preclinical Gene Editing Deal with Sangamo
-
Bicycle Signs US$1.7 B Immuno-oncology Collaboration with Genentech